Commercial | STI Pharma

let's join forces

Why STI Pharma

STI offers an expanding presence in the injectable market. Our management team has experience in product launch, sales, marketing, and distribution. The company has differentiated, strong C-level relationships with key GPOs and IDNs. Our partners benefit from our wholesale, hospital, retail and government experience and relationships. At STI we strive to maintain a reputation for quality, compliance and customer service.

We are currently focused on:

1

Product aquisitions & Licensing Oppourtunities

Its all about the Experience

Expertise and Market Access

We are committed to providing our partners with exceptional service.

Leadership
Launch Success
High Valued Relationships

Frank Mullery joined STI Pharma in the Fall of 2019 as President and Chief Commercial Officer
Frank brings over 15 years of experience in the pharmaceutical industry and was most recently at Mylan where he led the Institutional business and helped establish the company as a key player in the injectables market
Frank has launched over 40 injectable products, including complex products and Biosimilars. He also has established key parnterships with GPO's, IDN's and wholesale partners.

Read Bio

A team with previous experience launching over 40 injectables, with vast majority securing market leadership positions
Surgical strategies for each product developed by deep understanding of relationships between GPO’s, IDN’s, and Hospital members
Experience establishing unique contracting relationships with key customers, including value incentive, portfolio, and launch programs.

C-level relationships across nation’s top Institutional customers providing UNPRECEDENTED ACCESS
Unique contracting programs provide immediate VALUE CREATION
Creative alliances which have led to becoming PARTNER OF CHOICE

Know your market

Injectable Market

U.S. Generic Injectables Market Growth

Market Trends

The U.S. Generic Injectables market is expected to grow 7.5%, reaching $18bn by 2024

Oncology represents the largest therapeutics area, accounting for 36% of the U.S. Generic Injectables market in 2016

Injectable drugs are administered mainly in hospitals and clinics and sold to these organizations through contracts of GPOs

86% of generic injectables are being sold through the hospital

Limited competition and market penetration / high growth opportunities

Select opportunities also exist due to increasing shortages due to manufacturing complexity and strict requirements for quality, sterility and logistics of injectable drugs compared to other solid or liquid dosage forms

We've got you covered

Sales and Marketing

STI Sales and Marketing is made up of a team of seasoned industry professionals. Our expertise broadly includes sales of Branded, Generic, and OTC products with expertise in new product launches, sales management systems and analytics, distribution, operations and contracting.

View Bio

Contact Bruce

Bruce Walterick

Director, National Accounts & Commercial Excellence

Key Takeaways

Partnership Summary

1

STI Pharma leverages deep institutional market experience to optimize product performance

2

Team with proven track record of success launching over 40 injectable products including biosimilars and complex formulations

3

Partner of choice with GPO’s, IDN’s, and Hospitals with top to top relationships

4

Strategic sales force provides surgical launches with thorough understanding of value chain and GPO – Member relationships

5

Unique contracting agreements drive market share

6

Focused on growth through continued partner relationships

find us here

Partners

View As Text List

home - Company - commercial

Commercial Overview